Page 1 of 4

                       SECURITIES AND EXCHANGE COMMISSION

                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT


                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


      Date of Report (Date of earliest event reported) - September 26, 1997


                          Advanced Viral Research Corp.
             (Exact name of registrant as specified in its charter)


    Delaware                        33-2262-A                     59-2646820
(State or other juris-           (Commission File               (IRS Employer
diction of incorporation)            Number)                 Identification No.)


             1250 East Hallandale Beach Blvd.
             Suite 501
             Hallandale, Florida                                    33009
             (Address or principal executive offices             (zip code)


       Registrant's telephone number, including area code: (954) 458-7636




                                      NONE
          (Former name or former address, if changed since last report)






                                                                     Page 2 of 4

Item 1.           Changes in Control of Registrant

                  Not Applicable

Item 2.           Acquisition or Disposition of Assets

                  Not Applicable

Item 3.           Bankruptcy or Receivership

                  Not Applicable

Item 4.           Changes in Registrant's Certifying Accountant

                  Not Applicable

Item 5.           Other Events

                  On September 26, 1997 Advanced Viral  Research Corp.  ("ADVR")
                  sold  $3,000,000  face amount of its  ten-year 7%  Convertible
                  Debenture  to RBB Bank AG ("RBB") in an  offshore  transaction
                  pursuant to Regulation S under the Securities Act of 1933. The
                  Debenture  is  convertible  into common  shares of the Company
                  pursuant  to a  formula  more  particularly  described  in the
                  Debenture, a copy of which is attached hereto as Exhibit 4(h).
                  In  connection  with the  aforesaid  transaction,  the Company
                  issued to RBB three  Warrants  to purchase  its common  stock,
                  each such  Warrant  entitling  the holder to purchase  600,000
                  shares of the Company's  common stock.  The exercise prices of
                  the three  Warrants  are  $0.20,  $0.23 and $0.27 per  Warrant
                  share,  respectively.   Each  Warrant  contains  anti-dilution
                  provisions  which provide for the  adjustment of Warrant price
                  and Warrant shares as more  particularly set forth therein.  A
                  copy of the first of the three Warrants is attached  hereto as
                  Exhibit 4(i) with the second and third being  identical in all
                  respects except as set forth above.


Item 6.           Resignation of Registrant's Directors

                  Not Applicable

Item 7.           Financial Statements and Exhibits

                  (a)      Financial statements of business acquired

                           None





                                                                     Page 3 of 4

                  (b)      Pro forma financial information

                           None

                  (c)      Exhibits

                           10(aa)   Copy of Purchase  and Sale  agreement  dated
                                    September  26, 1997  between the Company and
                                    RBB Bank AG.

                           4(h)     The Company's 7% Convertible Debenture

                           4(i)     The Company's Warrant to Purchase Common
                                    Stock


Item 8.           Change in Fiscal Year

                  Not Applicable



                      [This Space Intentionally Left Blank]





                                                                     Page 4 of 4


                                   SIGNATURES

                  Pursuant to the requirements of the Securities Exchange Act of
1934,  the  registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.


                                     ADVANCED VIRAL RESEARCH CORP.
                                     (Registrant)


                                     By: /s/ William Bregman
                                        --------------------------
                                         William Bregman,
                                         Secretary-Treasurer


Date:  September 26, 1997







                                LIST OF EXHIBITS


10(aa)            Copy of Purchase and Sale Agreement dated September 26, 1997
                  between the Company and RBB Bank AG

4(h)              The Company's 7% Convertible Debenture

4(i)              The Company's Warrant to Purchase Common Stock